Research Paper Volume 15, Issue 9 pp 3480—3497
A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Figure 3. Survival analysis of 21 BCCGs in BC. (A) Heatmap displayed different expression patterns of the 21 BCCGs in the BC and control groups. (B) PCA analysis based on the 21 BCCGs could distinctly divide the BC group and control group. (C) K-M survival analysis of the 21 BCCGs in BC patients.